Variant report
Variant | nsv511336 |
---|---|
Chromosome Location | chr6:5898375-5900268 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:5422389..5423223-chr6:5898415..5898938,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12193326 | chr6:5898375-5898376 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs527294567 | chr6:5898383-5898384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548837341 | chr6:5898391-5898392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187248413 | chr6:5898396-5898397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs71557593 | chr6:5898450-5898451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs78356399 | chr6:5898621-5898622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531533117 | chr6:5898669-5898670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549686220 | chr6:5898697-5898698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10452676 | chr6:5898715-5898716 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs578245978 | chr6:5898730-5898731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538744379 | chr6:5898747-5898748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547876137 | chr6:5898751-5898752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115446505 | chr6:5898779-5898780 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144838744 | chr6:5898831-5898832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555038688 | chr6:5898839-5898840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537705207 | chr6:5898875-5898876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs192144524 | chr6:5898887-5898888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576788300 | chr6:5898891-5898892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537796839 | chr6:5898912-5898913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376582430 | chr6:5898913-5898914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558875244 | chr6:5898914-5898915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577378882 | chr6:5898950-5898951 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs75381504 | chr6:5898978-5898979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs67655188 | chr6:5898980-5898981 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs374874468 | chr6:5899009-5899010 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184512494 | chr6:5899010-5899011 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560576412 | chr6:5899067-5899068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs531501524 | chr6:5899077-5899078 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189324425 | chr6:5899125-5899126 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564887887 | chr6:5899132-5899133 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs66487772 | chr6:5899166-5899167 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs68186549 | chr6:5899192-5899193 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs566164923 | chr6:5899193-5899194 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530247907 | chr6:5899230-5899231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548601157 | chr6:5899255-5899256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570106438 | chr6:5899259-5899260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs66912941 | chr6:5899262-5899263 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs9504574 | chr6:5899301-5899302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570927681 | chr6:5899336-5899337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535235331 | chr6:5899369-5899370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573036607 | chr6:5899384-5899385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553184324 | chr6:5899433-5899434 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs9502373 | chr6:5899470-5899471 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544863426 | chr6:5899488-5899489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs9392727 | chr6:5899492-5899493 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs116636894 | chr6:5899519-5899520 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554131097 | chr6:5899570-5899571 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs575994791 | chr6:5899587-5899588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs75804408 | chr6:5899613-5899614 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565204161 | chr6:5899641-5899642 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Developmental delay | 19490664 | CNVD |
Cancer | 21183584 | CNVD |
Multiple Epiphyseal Dysplasia | 20877625 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Glaucoma | 18694899 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
dysmorphism | 22105932 | CNVD |
psychomotor delay | 22105932 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:5893000-5898400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr6:5893200-5899000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr6:5898200-5899800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr6:5898200-5900000 | Enhancers | NHDF-Ad | bronchial |
5 | chr6:5898400-5898600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr6:5898400-5899200 | Enhancers | Adipose Nuclei | Adipose |
7 | chr6:5898600-5898800 | Enhancers | Pancreas | Pancrea |
8 | chr6:5898600-5899400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
9 | chr6:5898800-5899000 | Weak transcription | Pancreas | Pancrea |
10 | chr6:5899000-5899200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
11 | chr6:5899200-5900600 | Weak transcription | Adipose Nuclei | Adipose |
12 | chr6:5899400-5899800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
13 | chr6:5899800-5905200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr6:5899800-5905400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
15 | chr6:5900000-5904400 | Weak transcription | NHDF-Ad | bronchial |